Coloplast A-S Aktie
WKN DE: A1KAGC / ISIN: DK0060448595
|
31.05.2018 17:09:31
|
Trading in Coloplast shares by board members, executives or associated persons
| Nasdaq Copenhagen 31 May 2018 | |
| Report on transactions of executives and related parties in Coloplast shares and related securities |
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns the exercise of share options (purchase and sale of shares).
| Name | Kristian Villumsen |
| Reason | Executive Vice President |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Share options |
| Transaction | Share option exercise (purchase of shares) |
| Trade date | 29 May 2018 |
| Market | NASDAQ Copenhagen |
| Number | 70,521 |
| Transaction value per share in DKK | 573.50 |
| Transaction value in DKK | 40,443,793.50 |
| Name | Kristian Villumsen |
| Reason | Executive Vice President |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Share options |
| Transaction | Share option exercise (sale of shares) |
| Trade date | 30 May 2018 |
| Market | NASDAQ Copenhagen |
| Number | 70,521 |
| Transaction value per share in DKK | 607.26 |
| Transaction value in DKK | 42,824,201.65 |
Calculation of share price:
When calculating the share price in connection with exercise of share options the purchase price is based on the strike price. The strike price is the share price at the grant date. In connection with sales the share price on the time of exercise is used.
Kind regards,
Coloplast A/S
Anne-Sofie Søegaard
Attachment
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Coloplast A-S (B)mehr Nachrichten
|
05.05.25 |
Coloplast A/S CEO Kristian Villumsen steps down as of today (GlobeNewswire) | |
|
05.05.25 |
Ausblick: Coloplast A-S (B) zieht Bilanz zum abgelaufenen Quartal (finanzen.net) | |
|
01.05.25 |
Coloplast A/S Revised guidance for FY 2024/25 (GlobeNewswire) | |
|
21.04.25 |
Erste Schätzungen: Coloplast A-S (B) verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
|
03.02.25 |
Ausblick: Coloplast A-S (B) zieht Bilanz zum abgelaufenen Quartal (finanzen.net) | |
|
20.01.25 |
Erste Schätzungen: Coloplast A-S (B) veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) |
Analysen zu Coloplast A-S (B)mehr Analysen
Aktien in diesem Artikel
| Coloplast A-S (B) | 87,18 | 0,53% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.